ArticleMolecular cancer2024

Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion.

Guo-Qian He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.